$CELG News Celgene drops 1.9%, among worst S&P 500

New Post Public Reply Private Reply Replies (0) Message Board

Jun 9, 2014 at 10:48 AM

$CELG News

Celgene drops 1.9%, among worst S&P 500 losers 9:32 a.m. May 29, 2014 - Sue Chang
Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - Russ Britt
The Nasdaq has a message to deliver 1:57 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:16 p.m. March 14, 2014 - Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 1:19 p.m. Jan. 13, 2014 - MarketWatch.com

Large Cap Biotech Stocks to Buy Leading the Comeback Rally 8:51 a.m. Today - 247WallSt.com
Focus On Catalysts To Cash In On Biotech: Jason Kolbert 1:30 p.m. June 6, 2014 - Seeking Alpha
Two Picks in Underappreciated Big Biotech 7:27 a.m. June 6, 2014 - Barrons.com
'Mad Money' Lightning Round: I'm Flying With American 6:00 a.m. June 6, 2014 - TheStreet.com
Cramer's Lightning Round - People Will Come Back To Charles Schwab (6/5/14) 5:02 a.m. June 6, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Follow Your Own Investment Path 8:08 p.m. June 5, 2014 - TheStreet.com
Celgene to Invest $25M in New Soon-Shiong Healthcare Venture 1:42 p.m. June 5, 2014 - TheStreet.com
Watch For Today's Momo Momentum Stock: Celgene (CELG) 12:52 p.m. June 5, 2014 - TheStreet.com
Stock Market News for June 05, 2014 - Market News 10:06 a.m. June 5, 2014 - Zacks.com
Jim Cramer's Top Stock Picks: PVH CELG REGN SKX 6:00 a.m. June 5, 2014 - TheStreet.com
Cramer's Mad Money - Skechers Is Totally Nailing It (6/4/14) 4:41 a.m. June 5, 2014 - Seeking Alpha
Celgene's (CELG) Management Hosts Jefferies Global Healthcare Conference (Transcript) 1:27 p.m. June 4, 2014 - Seeking Alpha
A Celgene Satellite: An Interview With Alliqua CEO Dave Johnson 8:19 a.m. June 4, 2014 - Seeking Alpha
NanoString to develop a companion diagnostic test for Celgene 5:03 p.m. June 3, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: CAT, CELG, BIDU 11:29 a.m. June 3, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – LGND VRX CELG LCI 2:00 p.m. June 2, 2014 - InvestorPlace.com
Stock Market News for June 02, 2014 - Market News 10:06 a.m. June 2, 2014 - Zacks.com
Celgene's Management Presents at Sanford C Bernstein Strategic Decisions Conference (Transcript) 8:46 p.m. May 29, 2014 - Seeking Alpha
Array BioPharma Collaborates with Biogen - Analyst Blog 5:10 p.m. May 29, 2014 - Zacks.com
Biogen Upgraded, Celgene Downgraded On Pipelines 2:18 p.m. May 29, 2014 - Investors Business Daily

Health Care Sector Equities Coverage -- Research on Neurocrine Biosciences, PDL BioPharma, Celgene, and Array BioPharma 7:50 a.m. June 6, 2014 - PR Newswire - PRF
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014 9:01 a.m. June 1, 2014 - BusinessWire - BZX
Veracyte, Foundation Medicine and Panacea Global Paving Way in Faster, More Accurate Cancer Diagnostics 9:53 a.m. May 29, 2014 - ACCESSWIRE
Breakthrough Innovation for Animal Health, Upcoming Conference Presentations, and New Treatment Options for Patients - Analyst Notes on Merck, Actavis, Celgene, Bristol-Myers Squibb and GSK 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Organizational Changes Strengthen and Expand Celgene Leadership Team 6:00 a.m. May 22, 2014 - BusinessWire - BZX
Marketing Authorizations, Study Results Presentations, FDA Response to Drug Application, and New Messaging Services - Analyst Notes on Johnson & Johnson, Merck, Celgene, Novartis and UnitedHealth 8:41 a.m. May 21, 2014 - PR Newswire - PRF
AADi Announces Licensing Agreement with Celgene for Nanotechnology-Based Drug Candidate 9:00 a.m. May 20, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in June 8:31 a.m. May 20, 2014 - BusinessWire - BZX
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index 8:05 a.m. May 19, 2014 - GlobeNewswire
Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014 5:19 p.m. May 14, 2014 - BusinessWire - BZX
Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver 9:31 a.m. May 14, 2014 - PR Newswire - PRF
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Celgene Prices $2.5 Billion of Senior Unsecured Notes 7:32 a.m. May 7, 2014 - BusinessWire - BZX
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Celgene Announces Offering of Senior Unsecured Notes 8:32 a.m. May 6, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver 9:31 a.m. May 1, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in May 8:30 a.m. April 25, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nasdaq Backs Marketplace to Boost Financial Literacy

Marketplace Gets a Leg Up with Nasdaq Grant Stumbled across this gem out of Saint Paul, and I gotta admit, it's nice to see folks focusing on the basics for a change. American Public Media's Marketplace lands a grant from the Nasdaq Foundation. And not just any grant—this one’s tagged as the Economic Opportunity Grant, all set to roll out expanded financial literacy...

Building a Detached Garage: What Texas Homeowners Should Know

Breaking Down Costs: Garage Building in Texas Now here's something that'll make you pause in your plans for extra car space or a new crafting palace—a detached garage doesn't come cheap! If you're in the Dallas-Fort Worth area, you might want to tune into what Jay Gravatt has to say. This guy from Rocking J Construction has seen it all when it comes to garages, and he's...

Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

Harbour BioMed's Batoclimab Injected Into Myasthenia Market

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Grid Hurdles Stalling Industrial Heat's Future Growth

The Grid's the New Ball and Chain Now that we're done fiddling with tech, let's talk grid. The industrial players itching to switch to electric heat have found a new villain: the grid. You'd think with resistance heating, electric boilers, electric arc furnaces, and the whole shebang ready to roll, it’d be a smooth ride. But nope, the bottleneck's the bloodstream...

CapCut's AI Tools Revolutionize Visual Content Creation

Riding the AI Content Creation Wave You know, once upon a time, crafting stunning visual content was a task that had creatives burning the midnight oil. But these days, it seems like artificial intelligence is shaking things up—and CapCut's sitting pretty at the helm of this revolution. Recently, Consumer365 gave CapCut a nod as a top contender for visual content...

ASPR AI Unveils Private Sales Agent Studio

Pushing Sales AI Into a Secure Future Picture a world where your most sensitive sales data stays safely behind your own digital doors. ASPR AI is shaking up the game by launching its Private Sales Agent Studio, a move that catapults enterprise sales management into a new era of control and customization. Why Private Means Business Here's the meat of it: sales AI usually...

Bybit's USD1 Program Extends with 27M WLFI Reward Pot

Bybit Extends USD1 Hold & Earn Program Man, when it comes to dangling a carrot, Bybit seems to know just the right length of stick to use. For those riding the crypto wave, they're reevaluating the worth of holding onto their digital coins, especially now that Bybit has renewed its USD1 Hold & Earn program. This isn't just a token gesture—it's a whopping 27 million WLFI...

Chery's TIGGO7 Crash Test Sparks Family Safety Confidence

Safety Is More Than a Buzzword for CHERY In the world of automobile mayhem, CHERY's "Guardian. For Family" event threw down the gauntlet, showing they ain't just playing with fire—they're harnessing it for family safety. Now, over in Longshan Crash Laboratory in Wuhu, we got to see the TIGGO7 take a 50 km/h head-on collision with a truck. Yeah, it's as dramatic as it...

Oakworth Capital's Strategic Gains: A Deep Dive

Oakworth Capital's Big Moves This Quarter Diving right into the Alabama-based Oakworth Capital's latest numbers, they did not pull any punches with a hefty 19% bump in net income. Now, in a world where banking can sometimes feel like riding a porcupine, Oakworth's ability to rise above speaks volumes. They clocked in at $17.2 million net income for the year-to-date period...